1. Mass, twice-yearly administration of azithromycin to
children between 1 and 59 months of age in communities in Niger previously not administered azithromycin significantly reduced
childhood mortality rates. 2. Communities given azithromycin for a third year, after receiving it the previous 2 years, had no significant change in
childhood mortality rates. Evidence Rating Level: 1 […]